Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target L Peyrin-Biroulet, W Sandborn, BE Sands, W Reinisch, W Bemelman, ... Official journal of the American College of Gastroenterology| ACG 110 (9 …, 2015 | 1803 | 2015 |
European evidence based consensus for endoscopy in inflammatory bowel disease V Annese, M Daperno, MD Rutter, A Amiot, P Bossuyt, J East, M Ferrante, ... Journal of Crohn's and Colitis 7 (12), 982-1018, 2013 | 914 | 2013 |
Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease J Rimola, S Rodríguez, O García-Bosch, I Ordás, E Ayala, M Aceituno, ... Gut 58 (8), 1113-1120, 2009 | 738 | 2009 |
Anti‐TNF monoclonal antibodies in inflammatory bowel disease: pharmacokinetics‐based dosing paradigms I Ordás, DR Mould, BG Feagan, WJ Sandborn Clinical Pharmacology & Therapeutics 91 (4), 635-646, 2012 | 585 | 2012 |
Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity J Rimola, I Ordás, S Rodriguez, O García-Bosch, M Aceituno, J Llach, ... Inflammatory bowel diseases 17 (8), 1759-1768, 2011 | 541 | 2011 |
Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease I Ordás, J Rimola, S Rodríguez, JM Paredes, MJ Martínez-Pérez, E Blanc, ... Gastroenterology 146 (2), 374-382. e1, 2014 | 408 | 2014 |
Development of the Lémann index to assess digestive tract damage in patients with Crohn's disease B Pariente, JY Mary, S Danese, Y Chowers, P De Cruz, G D’Haens, ... Gastroenterology 148 (1), 52-63. e3, 2015 | 326 | 2015 |
Safety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patients M Chaparro, I Ordás, E Cabré, V Garcia-Sanchez, G Bastida, M Peñalva, ... Inflammatory bowel diseases 19 (7), 1404-1410, 2013 | 323 | 2013 |
Characterization of inflammation and fibrosis in Crohn’s disease lesions by magnetic resonance imaging J Rimola, N Planell, S Rodríguez, S Delgado, I Ordás, A Ramírez-Morros, ... Official journal of the American College of Gastroenterology| ACG 110 (3 …, 2015 | 263 | 2015 |
Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations N Planell, JJ Lozano, R Mora-Buch, MC Masamunt, M Jimeno, I Ordás, ... Gut 62 (7), 967-976, 2013 | 247 | 2013 |
Therapeutic drug monitoring of tumor necrosis factor antagonists in inflammatory bowel disease I Ordás, BG Feagan, WJ Sandborn Clinical Gastroenterology and Hepatology 10 (10), 1079-1087, 2012 | 236 | 2012 |
Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy C Loras, JP Gisbert, M Mínguez, O Merino, L Bujanda, C Saro, ... Gut 59 (10), 1340-1346, 2010 | 199 | 2010 |
Alterations in the epithelial stem cell compartment could contribute to permanent changes in the mucosa of patients with ulcerative colitis I Dotti, R Mora-Buch, E Ferrer-Picón, N Planell, P Jung, MC Masamunt, ... Gut 66 (12), 2069-2079, 2017 | 190 | 2017 |
Intraperitoneal administration of autologous tolerogenic dendritic cells for refractory Crohn’s disease: a phase I study A Jauregui-Amezaga, R Cabezón, A Ramírez-Morros, C España, ... Journal of Crohn's and Colitis 9 (12), 1071-1078, 2015 | 171 | 2015 |
Early use of immunosuppressives or TNF antagonists for the treatment of Crohn's disease: time for a change I Ordas, BG Feagan, WJ Sandborn Gut 60 (12), 1754-1763, 2011 | 153 | 2011 |
Development and validation of a simplified magnetic resonance index of activity for Crohn’s disease I Ordás, J Rimola, I Alfaro, S Rodríguez, J Castro-Poceiro, ... Gastroenterology 157 (2), 432-439. e1, 2019 | 144 | 2019 |
Identification of inflammatory mediators in patients with Crohn's disease unresponsive to anti-TNFα therapy RF Leal, N Planell, R Kajekar, JJ Lozano, I Ordás, I Dotti, M Esteller, ... Gut 64 (2), 233-242, 2015 | 143 | 2015 |
Epidemiological risk factors in microscopic colitis: a prospective case–control study F Fernández-Bañares, MR de Sousa, A Salas, B Beltrán, M Piqueras, ... Inflammatory bowel diseases 19 (2), 411-417, 2013 | 119 | 2013 |
Comparison of three magnetic resonance enterography indices for grading activity in Crohn’s disease J Rimola, A Alvarez-Cofiño, T Pérez-Jeldres, C Ayuso, I Alfaro, ... Journal of gastroenterology 52, 585-593, 2017 | 111 | 2017 |
Risk of developing tuberculosis under anti-TNF treatment despite latent infection screening A Jauregui-Amezaga, F Turon, I Ordás, M Gallego, F Feu, E Ricart, ... Journal of Crohn's and Colitis 7 (3), 208-212, 2013 | 108 | 2013 |